Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
2,234 total articles
Colgate-Palmolive (CL) offers a defensive trade for 2026: steady cash generation, a mid-single-digit yield, and buyback support at a valuation that looks reasonable for a consumer staple. Enter on a near-term pullback, target a ~10% upside with a conservative stop, and hold through the next 6 months as fundamentals and macro conditions normalize.
LUCA Mining (LUCMF) is an OTC small-cap gold exposure trading with high volatility and heavy short activity. Price sits near $1.36 with mixed technicals and elevated short interest that can amplify moves. This idea lays out a tactical long: entry at $1.38, stop at $1.08, target at $1.95 over a mid-term horizon, with clear triggers and risk controls…
KKR is trading near oversold technicals and well below last year’s highs after a wave of negative headlines around private credit. With $744B AUM, recurring fee streams, and selective growth investments in data centers and sports assets, the selloff offers an asymmetric risk/reward. This is a tactical long with a clear stop and staged profit-taking…
Shares of Fiserv have been hammered over the last year, leaving a market-leading payments processor trading at single-digit multiples. With $4.6B of free cash flow, an enterprise value under $62B and improving operational initiatives under new leadership, the risk/reward favors long exposure for patient investors. This trade idea lays out an action…
Silicon Motion (SIMO) sits squarely in the path of a renewed memory up-cycle. After reporting $278.5M in Q4 sales and guiding Q1 revenue 76-84% higher year-over-year, the stock offers a tradeable long with defined risk-reward. We lay out entry, stop and target levels, the fundamental case, catalysts and what would force us to change our view.
Advanced Micro Devices (AMD) reported a strong Q4 with record revenue and solid profitability, but a conservative Q1 guide and a one-time China uplift scared the market. The share plunge creates a tactical long opportunity for investors willing to accept near-term volatility for exposure to secular AI/data-center growth. Trade plan: enter at $192.0…
Tenable trades at attractive cash-flow multiples (P/FCF ~9.4, EV/Sales ~2.6) despite negative GAAP EPS. The company’s Tenable One platform and recent AI exposure launch, plus industry recognition, create a clear path to revenue and margin expansion. This trade plan targets a recovery to $33 over a 180-trading-day horizon with a $19.55 stop.
Intellia (NTLA) sits at a crossroads: one pivotal Phase 3 topline for lonvoguran ziclumeran and progress toward a nexiguran ziclumeran Phase 3 enrollment milestone should drive material re-rating or renewed selling pressure. The company is a high-risk, high-reward biotech with a market cap near $1.3B, negative free cash flow and wide short interest…
PDD Holdings (PDD) has been knocked lower on negative sentiment around its Temu marketplace, but the share price now reflects a lot of bad news. With a market cap of about $145.4B, a trailing PE near 10, and a cash-rich profile relative to peers (operational strength implied by low multiple and resilient margins), PDD looks like a high-conviction l…
Wesco (WCC) is benefiting from data-center spending, broadband buildouts and electrification-related demand. The numbers show revenue strength and multiple expansion, but free cash flow conversion and leverage remain the gating factors for a durable rally. We favor a disciplined long with a clear stop and a mid-term horizon while watching cash gene…
Credit-rating names have come under pressure as the market frets over AI cutting into research and subscription margins. Moody's (MCO) has been sold hard: the stock trades at $461.17, sits well below recent moving averages, and shows an oversold RSI of 23.9. But its high ROE (56.7%), $2.4B free cash flow, and a $82.25B market cap argue the company …
Palantir (PLTR) is a buy after a sharp run-down. The stock sits below key moving averages with an RSI in the mid-20s, while fundamentals and recent contract wins point to continued high-single- to double-digit revenue growth in government AI. This is a mid-term swing trade that favors taking a controlled position now with a defined stop and a targe…
Celestica (CLS) is showing the characteristics of an aggressive growth pick: strong FCF generation, improving institutional interest, a recent product push into high-density AI storage, and a tight float after buybacks. At $299.82, the stock has momentum but still offers upside to the prior 52-week high on a continuation of AI/data-center spending.…
Meta is pushing the largest-capex AI buildout in Big Tech history. The market has punished near-term margins, but the company still generates strong cash flow, trades below frothy multiples for growth leaders, and shows bullish technicals. This trade targets a re-rate as advertisers and products monetize advanced AI features across the Family of Ap…
Mach Natural Resources (MNR) offers an attractive risk-reward for a mid-term long: a ~12.9% distribution yield, low EV/EBITDA near 5.6, and improving technical momentum. This trade targets a rebound toward the 52-week high area as the market re-rates capital-efficient producers in mature basins. Entry $11.75, target $16.50, stop $10.46 - horizon mi…
Aduro (ADUR) is showing tangible operational progress: pilot commissioning, successful steamcracking trials of Hydrochemolytic oil, selection of Chemelot for its first industrial plant, and fresh capital that keeps the demo project funded. For traders willing to accept execution risk, a disciplined long swing trade with entry near current levels an…
Exxon Mobil looks fundamentally cheap for a blue-chip integrated oil company: robust 2025 cash generation, low leverage, and a durable dividend put a floor under the stock. That said, price is hugging a 52-week high with an RSI north of 72, so an entry with defined risk or a pullback-first approach is prudent. This trade idea lays out a precise ent…
Banc of California (BANC) looks like a solid long-term trade: recent quarter showed improving net interest income and a $48.4M adjusted profit headline, management is executing CRE loan sales and buybacks, and the stock sits near $20 with a sub-1.0 P/B and an EPS-derived P/E in the high teens. This idea lays out an entry at $20.00, a conservative s…
MGM looks attractively priced on an EV/EBITDA of ~6.4 with >$1.36B of free cash flow and a $10.0B market cap. Operational headwinds from 2025 have left sentiment muted, but recent strategic moves, digital/international growth opportunities and improving technicals support a long trade. Entry $36.00, stop $33.00, target $42.00 - horizon ~180 trading…
Hexcel (HXL) supplies advanced composite materials to aerospace, defense and industrial markets. With aircraft production rates rising and demand for carbon-fiber structures increasing, I expect Hexcel's earnings to ramp aggressively in FY2026. This is a tactical long idea with a defined entry at $83.21, stop at $72.00 and target at $105.00 on a 18…
Constellium is a high-beta aluminum producer with built-in pricing pass-through and targeted product investments into battery foilstock and aerospace alloys. We like a tactical long: entry $24.00, stop $21.00, target $30.00 over a mid-term horizon (45 trading days). The trade balances cyclical upside from aluminum and contract/procurement protectio…
Cadre Holdings is a makers-and-distributor of protective equipment that appears positioned to win a material share of rising nuclear safety and critical-infrastructure spend. Fundamentals show healthy cash flow and a clean balance sheet; valuation at $1.68B market cap still requires multiple compression to reflect slower growth, making the next con…
LUCMF is an OTC-listed junior mining name trading at $1.445 with constructive technicals (RSI 63, MACD bullish) and an elevated but falling short interest profile. With market attention on its ramp-up narrative and metals prices supportive, we favor a directional long trade over the mid-term (45 trading days) while acknowledging execution and liqui…
AbbVie reported solid Q4 2025 results on 02/04/2026 with $16.62B in sales and adjusted EPS of $2.71, driven by Skyrizi and Rinvoq offsetting Humira declines. The stock sold off despite the beat. Given a $388B market cap, nearly $20B in free cash flow, and technicals that have stabilized, a mid-term long trade with a defined stop and target offers a…
Kosmos (KOS) trades like a levered oil bet: cheap on headline multiples, operationally levered to production recovery and oil prices, and heavily shorted. For traders willing to accept elevated risk, a disciplined long with a clear entry, stop and target offers asymmetric upside if oil and project execution improve over the next 6-8 weeks.
